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dence	 interval	 [CI]	8–76).	The	magnitude	of	this	 increase	varied	by	season	but	was	
greatest	among	pregnancies	with	high	influenza	virus	circulation	during	the	third	tri-
mester.	Birth	weight	 increased	by	111	g	 (95%	CI	−51	 to	273)	when	75%–100%	of	
a	pregnancy’s	third	trimester	had	high	influenza	virus	circulation	versus	38	g	(95%	CI	
−6	 to	 81)	when	0%–25%	of	 a	 pregnancy’s	 third	 trimester	 had	 high	 influenza	 virus	
	circulation.	However,	these	results	were	nonsignificant.
Conclusion:	 Seasonal	 maternal	 influenza	 vaccination	 in	 rural	 Nepal	 increased	 birth	
weight;	the	magnitude	appeared	larger	during	periods	of	high	influenza	virus	circulation.
ClinicalTrials.gov: NCT01034254.
K E Y W O R D S
Influenza;	Low	birth	weight;	Nepal;	Pregnancy;	Preterm;	Small	for	gestational	age;	Vaccination
1  | INTRODUCTION
In	 2010,	 influenza	 infection	 accounted	 for	 19	200	000	 disability-	
adjusted	 life	 years	worldwide.1	 Pregnant	women	 are	 at	 particularly	
high	 risk	 of	 complications	 from	 influenza	 infection.2	 WHO	 recom-
mends	vaccination	for	pregnant	women.3
One	 study	 showed	 markedly	 increased	 innate	 and	 adaptive	
immune	responses	to	the	influenza	vaccine	when	comparing	pregnant	
with	 non-	pregnant	women,4	 suggesting	 that	 these	 responses	might	
underpin	increased	rates	of	morbidity	and	mortality	among	pregnant	




©	2017	The	Authors.	International Journal of Gynecology & Obstetrics	published	by	John	Wiley	&	Sons	Ltd	on	behalf	of	International	Federation	of	Gynecology	and	
Obstetrics
66  |     KozuKi ET AL.
during	early	stages.5	Maternal	influenza	infection	has	also	been	linked	
with	fetal	growth	restriction,	preterm	delivery,	and	fetal	loss.6
Neonates	 born	 growth	 restricted	 and/or	 preterm	 are	 likely	 to	






Observational	 studies	 and	 randomized	 controlled	 trials	 (RCTs)	
exploring	the	effect	of	maternal	influenza	vaccination	on	rates	of	SGA	
and	 preterm	 delivery	 have	 reported	mixed	 findings.10–15	 The	Nepal	
Mothers’	Gift	Trial	was	an	RCT	of	maternal	influenza	vaccination	with	
two	annual	cohorts	of	pregnant	women	residing	in	a	rural	area	of	this	
country.15,16	The	 primary	 outcomes	were	maternal	 influenza-	like	 ill-












2  | MATERIALS AND METHODS
A	secondary	analysis	was	performed	using	the	data	from	an	RCT	that	

























cohorts	 were	 randomly	 allocated	 to	 receive	 a	 trivalent	 inactivated	


























data	 on	 pregnancy	 length	 could	 still	 be	 contributed.	A	 birth	weight	
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influenza	 episode	 during	 pregnancy	whereas	 2710	 (98.9%)	 did	 not.	
Additionally,	175	(6.4%)	women	experienced	at	least	one	episode	of	
influenza-	like	illness	during	pregnancy,	whereas	2566	(93.6%)	did	not.
Table	 S1	 presents	 birthweight	 stratified	 by	whether	 the	mother	
experienced	 influenza	 or	 influenza-	like	 illness.	 The	 adjusted	 regres-
sion	 results	 showed	 that	 the	 neonates	 of	mothers	with	 laboratory-	
confirmed	influenza	at	any	point	in	pregnancy	were	on	average	55	g	





illness	 (70	g,	 95%	CI	 −139	 to	 −2).	The	 total	 duration	 of	 illness	was	
1–26	days	 (median	 4	days)	 for	 those	with	 influenza	 and	 1–12	days	
(median	3	days)	 for	 those	with	 influenza-	like	 illness.	The	duration	of	
such	illness	was	not	associated	with	birth	weight	(data	not	shown).
The	 birth	 weight	 distribution	 in	 the	 placebo	 and	 vaccination	


















































A	 dose-	response	 relationship	 between	 exposure	 to	 high	 influ-
enza	 circulation	 and	 pregnancy	 length	 was	 observed	 but	 was	 not	
TABLE  2 Birth	weight	distribution,	by	vaccine	typea	and	vaccination	status.
Birth weight
Vaccine 1 Vaccine 2 Combined
Placebo (n=993) Vaccine (n=1030) Placebo (n=368) Vaccine (n=350) Placebo (n=1361) Vaccine (n=1380)
Mean,	g 2749 2785 2796 2859 2762 2804
Median,	g 2760 2800 2790 2860 2770 2810
Interquartile	range,	g 2460–3040 2520–3080 2520–3075 2560–3150 2470–3050 2520–3100
Range,	g 820–4420 1260–4110 1360–4140 1590–4800 820–4420 1260–4800
Low	birth	weightb 278 (28.0) 239	(23.2) 87	(23.6) 76 (21.7) 365	(26.8) 315	(22.8)
aVaccine	types	are	described	in	Appendix	S1.
bValues	given	as	number	(percentage).
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statistically	 significant	 (Table	 S3).	However,	 a	 statistically	 significant	
increase	 in	 pregnancy	 length	was	 found	 among	mothers	who	were	
vaccinated	between	26	weeks	and	less	than	30	weeks,	when	at	least	
half	of	their	third	trimester	had	been	exposed	to	high	influenza	virus	
circulation.	When	 removing	 the	 circulation	 stratification,	 there	was	














Maternal	 influenza	 vaccination	 increased	 birth	 weight	 among	 live	
births	 in	 the	 present	 study.	 The	 magnitude	 differed	 by	 season,	
appearing	 greatest	 among	 pregnancies	 for	which	 the	 third	 trimes-
ter	occurred	at	a	time	of	high	 influenza	virus	circulation;	however,	
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Previous	 observational	 studies	 reported	 mixed	 results	 regarding	
the	effect	of	maternal	 influenza	vaccination	on	birth	outcomes.	Data	
collected	 in	 the	USA	between	2004	 and	2009	 showed	no	 effect	 on	
preterm	birth	 or	 SGA,19	 although	 rates	 of	 these	 outcomes	 are	much	
lower	 in	 the	USA	than	 in	 low-	income	countries.	Data	 from	the	2009	












tency	of	the	present	findings	with	the	Bangladeshi	study14 could imply 
a	regional	difference.	The	LBW	and	SGA	rates	are	substantially	higher	
in	Asia	than	in	Sub-	Saharan	Africa,21	which	might	indicate	varying	eti-
ological	 factors	 that	 affect	birth	weight.	An	outcome	of	 LBW,	which	















outcomes	 through	 other	mechanisms.	Animal	 studies	 have	 indicated	














Combined Vaccinated at <26 wk Vaccinated at 26–<30 wk Vaccinated at ≥30 wk
n β (95% CI) n β (95% CI) n β (95% CI) n β (95% CI)
0%	to	<25%	of	third	trimester	 
in	high	circulation	period
Placebo 1142 Ref. 779 Ref. 225 Ref. 138 Ref.
Vaccinated 1130 38	(−6	to	81) 766 42	(−11	to	95) 203 30	(−68	to	128) 161 39	(−85	to	163)
25%	to	<50%	of	third	trimester	 
in	high	circulation	period
Placebo 367 Ref. 244 Ref. 94 Ref. 29 Ref.
Vaccinated 384 21	(−49	to	90) 245 51	(−37	to	138) 114 −80	(−205	to	44) 25 109	(−136	to	353)
50%	to	<75%	of	third	trimester	 
in	high	circulation	period
Placebo 240 Ref. 136 Ref. 67 Ref. 37 Ref.
Vaccinated 236 66	(−32	to	165) 136 64	(−59	to	186) 64 32	(−157	to	222) 36 124	(−175	to	423)
75%–100%	of	third	trimester	 
in	high	circulation	period
Placebo 90 Ref. 43 Ref. 29 Ref. 18 Ref.
Vaccinated 86 111	(−51	to	273) 47 118	(−119	to	354) 24 304	(−14	to	622) 25 −86	(−397	to	225)
Combined
Placebo 1845 Ref. 1206 Ref. 416 Ref. 223 Ref.
Vaccinated 1843 42	(8	to	76) 1191 48	(6	to	90) 405 23	(−47	to	93) 247 48	(−52	to	148)
Abbreviation:	CI,	confidence	interval.
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virus.	Given	 that	 the	greatest	 fetal	weight	gain	occurs	 late	 in	preg-
nancy,27	the	present	study	focused	on	such	exposure	during	the	third	
trimester;	however,	exposure	at	an	earlier	stage	 in	pregnancy	could	
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Figure S5.	 Bimonthly	 mean	 birth	 weight	 against	 weekly	 influenza	
	circulation,	by	influenza	type.
Table S1.	 Birth	 weight	 distribution	 (restricted	 to	 those	 measured	
within	 72	hours	 of	 birth),	 comparing	 women	who	 had	 influenza	 or	
influenza-	like	illness	during	pregnancy	with	those	who	did	not.
Table S2.	Effect	of	maternal	vaccination	on	birth	outcomes,	stratified	
by	calendar	time	of	vaccination.
Table S3.	Effect	of	vaccination	on	gestational	age,	stratified	by	third	
trimester	exposure	to	high	influenza	circulation	and	timing	of	vaccina-
tion	in	pregnancy.
Appendix S1.	Influenza	vaccine	type.
